metaraminol has been researched along with Left Ventricular Dysfunction in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sideris, DA | 1 |
| Pappas, S | 1 |
| Siongas, K | 1 |
| Grekas, G | 1 |
| Argyri-Greka, O | 1 |
| Koundouris, E | 1 |
| Foussas, S | 1 |
| Simões, MV | 1 |
| Maciel, BC | 1 |
| Marin-Neto, JA | 1 |
2 other studies available for metaraminol and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Effect of preload and afterload on ventricular arrhythmogenesis.
Topics: Animals; Bandages; Disease Models, Animal; Dogs; Electrocardiography; Heart Rate; Metaraminol; Tachy | 1995 |
Reversible segmental left-ventricular dysfunction caused by accidental administration of sympathomimetic drug in human.
Topics: Adult; Female; Humans; Hypotension; Medication Errors; Metaraminol; Shock, Cardiogenic; Sympathomime | 1997 |